REGISTERED NUMBER: 08006217 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 March 2026

for

MGC Diagnostics Limited

Page

Company Information

1

Balance Sheet

2

DIRECTOR:

Dr M G Cowling

SECRETARY:

Mrs S L Cowling

REGISTERED OFFICE:

3 - 5 College Street

Nottingham

Nottinghamshire

NG1 5AQ

REGISTERED NUMBER:

08006217 (England and Wales)

FIXED ASSETS

216

270

CURRENT ASSETS

112,791

109,011

PREPAYMENTS AND ACCRUED INCOME

1,291

1,291

CREDITORS

Amounts falling due within one year

(51,404

)

(58,229

)

NET CURRENT ASSETS

62,678

52,073

TOTAL ASSETS LESS CURRENT LIABILITIES

62,894

52,343

ACCRUALS AND DEFERRED INCOME

(1,330

)

(1,307

)

NET ASSETS

61,564

51,036

CAPITAL AND RESERVES

61,564

51,036

NOTES TO THE FINANCIAL STATEMENTS

1.	GOING CONCERN

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future and for at least 12 months from the date of approving these financial statements. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2025 - 1 ) .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 3 November 2026 and were signed by:

Dr M G Cowling - Director